FTA: “The different endpoints suggest that nicotine might be lowering viral load, or something of that nature, and nicotine is known to have some funky immunol

FTA: “The different endpoints suggest that nicotine might be lowering viral load, or something of that nature, and nicotine is known to have some funky immunological effects. But the benefit, if it exists, can’t be attributed to nicotine until that’s established independently.” Fortunately this might be easy to test given that transdermal nicotine patches can deliver nicotine without the associated smoke, tar, morning cough, etc. that the article mentions in passing. I’m curious how this plays out.